Citius Oncology, Inc. Public Float
Citius Oncology, Inc. (CTOR) had Public Float of $5.10 million as of 2025-03-31, per its 10-K filed 2025-12-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2025-12-23
- 2025-03-31: Entity Public Float $5.10M.
- 2024-03-28: Entity Public Float $47.70T; Entity Public Float as first filed $47.70M.
- 2023-06-30: Entity Public Float $69.50M.
- 2022-06-30: Entity Public Float $0.00.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-03-31 | $5.10M 10-K · filed 2025-12-23 | |
| 2024-03-28 | $47.70T 10-K/A · filed 2025-01-27 | $47.70M 10-K · filed 2024-12-27 |
| 2023-06-30 | $69.50M 10-K · filed 2024-04-16 | |
| 2022-06-30 | $0.00 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |